ATM and systemic sclerosis: This SSc classification describes cutaneous changes in symptomatic patients with detectable (anti-ATA, anti-ACA, anti-RNA polymerase III) but does not adequately address non-cutaneous respiratory, gastrointestinal or endocrine symptoms that are early disease features (8).